COVID-19 Therapeutic Alert: Azithromycin in the Management of COVID-19 (SARS-CoV-2) Positive Patients, DHSC

RECOVERY trial showed no significant clinical benefit of either oral or IV azithromycin in patients hospitalised with COVID-19. It is now recommended azithromycin should NOT be used in this population unless there are additional indications for which its use remains appropriate.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news